Letter to FDA: Goldstein Nomination for NDAC Share page: With this letter, the Consumer Healthcare Products Association expresses its great interest in the selection of the industry representative to serve on the Nonprescription Drugs Advisory Committee. Download Document Issues: OTC Medicines Related Posts Press Releases and Statements CHPA Response to Study Examining Prescription Acid Reflux Drugs Apr 25, 2024 Articles Polibrief: Consumer Data Privacy: State Efforts to Preserve Privacy Apr 16, 2024 Press Releases and Statements Self-Care Industry Representatives Participate in Capitol Hill Briefing Highlighting Legislative Priorities Apr 11, 2024